INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-434 Cr | ₹-208 Cr | ₹-121 Cr | ₹-67 Cr | ₹-56 Cr |
What is the latest Cash Flow from Investing Activities ratio of INDOCO REMEDIES ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-434 Cr |
Mar2023 | ₹-208 Cr |
Mar2022 | ₹-121 Cr |
Mar2021 | ₹-67 Cr |
Mar2020 | ₹-56 Cr |
How is Cash Flow from Investing Activities of INDOCO REMEDIES Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-434 Cr | Negative | |
Mar2023 | ₹-208 Cr | Negative | |
Mar2022 | ₹-121 Cr | Negative | |
Mar2021 | ₹-67 Cr | Negative | |
Mar2020 | ₹-56 Cr | - |
Compare Cash Flow from Investing Activities of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹3,062.9 Cr | -0.8% | 5.2% | -16.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹446,684.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,935.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹121,639.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹115,931.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,876.4 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | -0.8% |
5.2% |
-16.7% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses